Calcitonin Salmon Market Report 2026

Calcitonin Salmon Market Overview

• Calcitonin Salmon market size has reached to $1.28 billion in 2025 • Expected to grow to $1.69 billion in 2030 at a compound annual growth rate (CAGR) of 5.6% • Growth Driver: Rising Osteoporosis Cases Fueling The Growth Of The Market Due To Increasing Aging Population • Market Trend: Fresenius Kabi Enhances Bone Disorder Treatments With Innovative Calcitonin Salmon Injection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Calcitonin Salmon Market?

Calcitonin-salmon is a synthetic or recombinant form of the hormone calcitonin, derived initially from salmon, that is used as a medication to help regulate calcium levels and maintain bone health. It works by inhibiting the activity of osteoclasts, the cells responsible for breaking down bone, slowing bone loss, and reducing calcium levels in the blood. The main types of calcitonin salmon are spray and injection. Spray in calcitonin salmon refers to the nasal spray formulation used for delivering the hormone to treat conditions such as osteoporosis. These are used for various dosage forms, including intravenous, subcutaneous, nasal spray, and others, and are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies. The various applications include osteoporosis, paget's disease of bone, hypercalcemia, myeloma, and others and are used by various end users such as clinics, pharmacies, online pharmacies, and others.

What Is The Calcitonin Salmon Market Growth Forecast?

The calcitonin salmon market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to geriatric population growth, preference for non-invasive delivery, synthetic peptide innovation, bone health awareness, specialty endocrinology care. Major trends in the forecast period include continued use in osteoporosis management, preference for nasal spray formulations, shift toward synthetic and recombinant products, growth in geriatric bone disorder treatment, stable demand in hypercalcemia management.

Global Calcitonin Salmon Market Segmentation

1) By Type: Spray, Injection 2) By Dosage Form: Intravenous, Subcutaneous, Nasal Spray, Other Dosage Forms 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 4) By Application: Osteoporosis, Paget's Disease Of Bone, Hypercalcemia, Myeloma, Other Applications 5) By End User: Hospitals, Clinics, Pharmacies, Online Pharmacies, Other End Users Subsegments: 1) By Spray: Nasal Spray, Oral Spray 2) By Injection: Subcutaneous Injection, Intramuscular Injection, Intravenous Injection

What Are The Drivers Of The Calcitonin Salmon Market?

The increasing prevalence of osteoporosis is expected to propel the growth of the calcitonin salmon market going forward. Osteoporosis refers to a medical condition characterized by decreased bone density and increased fracture risk, primarily affecting older adults, especially postmenopausal women. Osteoporosis is rising due to increasing life expectancy, leading to a larger aging population more susceptible to bone density loss. Calcitonin salmon helps manage osteoporosis by inhibiting bone resorption, slowing bone loss, and helping maintain bone density in affected individuals For instance, in August 2024, according to Healthy Bones Australia, an Australia-based nonprofit organization focused on osteoporosis prevention and bone health, an estimated 6.2 million Australians aged 50 years and older, representing about 67 percent of this age group, were living with poor bone health in 2023, and around 23 percent of these individuals were affected by osteoporosis. Therefore, the increasing prevalence of osteoporosis is driving the growth of the calcitonin salmon industry. The rising investments in healthcare infrastructure are expected to propel the growth of the calcitonin salmon market going forward. Healthcare infrastructure refers to the foundational physical and organizational facilities such as hospitals, clinics, medical equipment, and health-system capital assets, needed to deliver health services. Healthcare infrastructure investment is rising due to increased government allocations aimed at modernizing facilities and expanding system capacity. Calcitonin salmon therapies experience increased availability and use as rising healthcare-infrastructure investment expands clinical facilities and improves patient access. For instance, in December 2024, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal government health data and statistical authority, U.S. health care spending grew 7.5% in 2023, reaching $4.9 trillion or $14,570 per person, and accounted for 17.6% of the nation’s GDP. Therefore, the rising investments in healthcare infrastructure are driving the growth for the calcitonin salmon industry.

Key Players In The Global Calcitonin Salmon Market

Major companies operating in the calcitonin salmon market are Sanofi S.A, Boehringer Ingelheim International GmbH, Viatris Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals plc, Endo International plc, Asahi Kasei Pharma Corporation, Anhui Anke Biotechnology (Group) Co. Ltd., Hybio Pharmaceutical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Santa Cruz Biotechnology Inc., HRV Global Life Sciences Private Limited, AdvaCare Pharma USA LLC, BCN Peptides S.L., Leucadia Pharmaceuticals Inc., Polypeptide Group AB, LKT Laboratories Inc.

Global Calcitonin Salmon Market Trends and Insights

Major companies in the calcitonin salmon market are focusing on developing innovative solutions, such as calcium regulators, to enhance treatment effectiveness and improve patient outcomes. A calcium regulator is a substance or mechanism that helps control calcium levels in the blood and bones, ensuring proper bone formation, maintenance, and metabolic balance. For instance, in February 2025, Fresenius Kabi, a Germany-based pharmaceutical company, launched calcitonin salmon injection, USP synthetic, to treat symptomatic Paget's disease of the bone and hypercalcemia. This synthetic formulation is indicated for symptomatic Paget's disease of the bone, hypercalcemia, and postmenopausal osteoporosis when alternative treatments are unsuitable. Packaged in 400 I.U./2 mL (200 I.U./mL) multi-dose vials, the product is entirely formulated, filled, and packaged in the United States, emphasizing Fresenius Kabi's commitment to strengthening domestic pharmaceutical manufacturing and supply chains. The introduction of this injection enhances the company's generic injectables portfolio, aiming to provide affordable and reliable treatment options for patients.

Regional Insights

North America was the largest region in the calcitonin salmon market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Calcitonin Salmon Market?

The calcitonin salmon market consists of sales of nasal spray, auto-injectors, lyophilized powder, nasal gel, and oral spray or tablet. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Calcitonin Salmon Market Report 2026?

The calcitonin salmon market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the calcitonin salmon industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.